138 related articles for article (PubMed ID: 8795579)
1. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
Müller W; Schneiders A; Meier S; Hommel G; Gabbert HE
Br J Cancer; 1996 Sep; 74(5):759-65. PubMed ID: 8795579
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.
Youssef EM; Matsuda T; Takada N; Osugi H; Higashino M; Kinoshita H; Watanabe T; Katsura Y; Wanibuchi H; Fukushima S
Cancer; 1995 Aug; 76(3):358-66. PubMed ID: 8625114
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1.
Broll R; Mahlke C; Best R; Schimmelpenning H; Strik MW; Schiedeck T; Bruch HP; Duchrow M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):49-54. PubMed ID: 9498835
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.
Sarbia M; Bittinger F; Porschen R; Dutkowski P; Torzewski M; Willers R; Gabbert HE
Br J Cancer; 1996 Oct; 74(7):1012-6. PubMed ID: 8855967
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
6. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
8. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
Skalova A; Leivo I; Von Boguslawsky K; Saksela E
J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
[TBL] [Abstract][Full Text] [Related]
10. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of the proliferative activity of esophageal carcinoma with invasion beyond the muscularis mucosae; immunohistochemical analysis using MIB-1 for the Ki-67 antigen.
Chino O; Osamura Y; Kise Y; Nishi T; Shimada H; Tanaka M; Kijima H; Makuuchi H
Tokai J Exp Clin Med; 2007 Dec; 32(4):115-20. PubMed ID: 21318949
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations.
Semczuk A; Skomra D; Cybulski M; Jakowicki JA
Histochem J; 2001 Apr; 33(4):193-200. PubMed ID: 11550800
[TBL] [Abstract][Full Text] [Related]
14. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
15. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma.
Gabbert HE; Müller W; Schneiders A; Meier S; Hommel G
Cancer; 1995 Sep; 76(5):720-6. PubMed ID: 8625172
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer.
Kikuyama S; Kubota T; Shimizu K; Miyakita M
Oncol Rep; 1998; 5(4):867-70. PubMed ID: 9625834
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2010; 51(4):655-61. PubMed ID: 21103622
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
